nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Dacarbazine—sarcoma	0.103	0.282	CbGbCtD
Rifabutin—CYP3A4—Thiotepa—sarcoma	0.0974	0.266	CbGbCtD
Rifabutin—CYP1A2—Etoposide—sarcoma	0.0504	0.138	CbGbCtD
Rifabutin—CYP3A4—Mitoxantrone—sarcoma	0.0419	0.114	CbGbCtD
Rifabutin—CYP3A4—Vincristine—sarcoma	0.0288	0.0788	CbGbCtD
Rifabutin—CYP3A4—Etoposide—sarcoma	0.0264	0.0722	CbGbCtD
Rifabutin—HSP90AA1—larynx—sarcoma	0.0238	0.126	CbGeAlD
Rifabutin—CYP3A4—Doxorubicin—sarcoma	0.018	0.0492	CbGbCtD
Rifabutin—HSP90B1—mammary gland—sarcoma	0.0105	0.0557	CbGeAlD
Rifabutin—HSP90AA1—endothelium—sarcoma	0.00956	0.0505	CbGeAlD
Rifabutin—HSP90AA1—mammary gland—sarcoma	0.00771	0.0407	CbGeAlD
Rifabutin—HSP90B1—myometrium—sarcoma	0.00748	0.0395	CbGeAlD
Rifabutin—HSP90B1—embryo—sarcoma	0.00719	0.038	CbGeAlD
Rifabutin—HSP90B1—seminal vesicle—sarcoma	0.00675	0.0357	CbGeAlD
Rifabutin—HSP90B1—hematopoietic system—sarcoma	0.00642	0.0339	CbGeAlD
Rifabutin—HSP90B1—connective tissue—sarcoma	0.00618	0.0326	CbGeAlD
Rifabutin—HSP90B1—smooth muscle tissue—sarcoma	0.00565	0.0299	CbGeAlD
Rifabutin—HSP90B1—skin of body—sarcoma	0.00558	0.0295	CbGeAlD
Rifabutin—HSP90AA1—myometrium—sarcoma	0.00547	0.0289	CbGeAlD
Rifabutin—HSP90AA1—embryo—sarcoma	0.00526	0.0278	CbGeAlD
Rifabutin—HSP90AA1—seminal vesicle—sarcoma	0.00494	0.0261	CbGeAlD
Rifabutin—HSP90B1—cardiac atrium—sarcoma	0.00487	0.0257	CbGeAlD
Rifabutin—HSP90B1—uterus—sarcoma	0.00485	0.0256	CbGeAlD
Rifabutin—HSP90AA1—hematopoietic system—sarcoma	0.00469	0.0248	CbGeAlD
Rifabutin—HSP90AA1—connective tissue—sarcoma	0.00452	0.0239	CbGeAlD
Rifabutin—HSP90B1—lymphoid tissue—sarcoma	0.00452	0.0239	CbGeAlD
Rifabutin—HSP90B1—tendon—sarcoma	0.00425	0.0224	CbGeAlD
Rifabutin—HSP90AA1—smooth muscle tissue—sarcoma	0.00414	0.0218	CbGeAlD
Rifabutin—HSP90B1—bone marrow—sarcoma	0.00412	0.0217	CbGeAlD
Rifabutin—HSP90AA1—skin of body—sarcoma	0.00408	0.0216	CbGeAlD
Rifabutin—HSP90AA1—cardiac atrium—sarcoma	0.00356	0.0188	CbGeAlD
Rifabutin—HSP90AA1—uterus—sarcoma	0.00355	0.0187	CbGeAlD
Rifabutin—HSP90B1—testis—sarcoma	0.00352	0.0186	CbGeAlD
Rifabutin—HSP90B1—liver—sarcoma	0.00333	0.0176	CbGeAlD
Rifabutin—HSP90AA1—lymphoid tissue—sarcoma	0.00331	0.0175	CbGeAlD
Rifabutin—HSP90AA1—tendon—sarcoma	0.00311	0.0164	CbGeAlD
Rifabutin—HSP90AA1—bone marrow—sarcoma	0.00301	0.0159	CbGeAlD
Rifabutin—HSP90AA1—testis—sarcoma	0.00257	0.0136	CbGeAlD
Rifabutin—HSP90B1—lymph node—sarcoma	0.00255	0.0135	CbGeAlD
Rifabutin—HSP90AA1—liver—sarcoma	0.00243	0.0128	CbGeAlD
Rifabutin—HSP90AA1—lymph node—sarcoma	0.00186	0.00985	CbGeAlD
Rifabutin—CYP1A2—hematopoietic system—sarcoma	0.00152	0.00802	CbGeAlD
Rifabutin—CYP3A4—hematopoietic system—sarcoma	0.0011	0.0058	CbGeAlD
Rifabutin—Neutropenia—Mitoxantrone—sarcoma	0.00106	0.00472	CcSEcCtD
Rifabutin—Hepatitis—Dactinomycin—sarcoma	0.00104	0.00464	CcSEcCtD
Rifabutin—Connective tissue disorder—Thiotepa—sarcoma	0.00103	0.00459	CcSEcCtD
Rifabutin—Jaundice—Mitoxantrone—sarcoma	0.000987	0.00438	CcSEcCtD
Rifabutin—Eye disorder—Thiotepa—sarcoma	0.000984	0.00437	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Etoposide—sarcoma	0.000964	0.00428	CcSEcCtD
Rifabutin—Immune system disorder—Thiotepa—sarcoma	0.000951	0.00422	CcSEcCtD
Rifabutin—Agranulocytosis—Mitoxantrone—sarcoma	0.000945	0.0042	CcSEcCtD
Rifabutin—Skin discolouration—Epirubicin—sarcoma	0.000934	0.00415	CcSEcCtD
Rifabutin—Bronchospasm—Etoposide—sarcoma	0.000929	0.00413	CcSEcCtD
Rifabutin—Connective tissue disorder—Vincristine—sarcoma	0.000917	0.00407	CcSEcCtD
Rifabutin—Hepatitis—Mitoxantrone—sarcoma	0.000909	0.00404	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000903	0.00411	CbGpPWpGaD
Rifabutin—Pancytopenia—Etoposide—sarcoma	0.000897	0.00398	CcSEcCtD
Rifabutin—Blood bilirubin increased—Epirubicin—sarcoma	0.000892	0.00396	CcSEcCtD
Rifabutin—HSP90AA1—LKB1 signaling events—MYC—sarcoma	0.000888	0.00404	CbGpPWpGaD
Rifabutin—Neutropenia—Etoposide—sarcoma	0.000883	0.00392	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000881	0.00401	CbGpPWpGaD
Rifabutin—Skin discolouration—Doxorubicin—sarcoma	0.000865	0.00384	CcSEcCtD
Rifabutin—Anaemia—Thiotepa—sarcoma	0.000847	0.00376	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—KDR—sarcoma	0.000844	0.00384	CbGpPWpGaD
Rifabutin—Phosphatase alkaline increased—Epirubicin—sarcoma	0.000844	0.00375	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000841	0.00383	CbGpPWpGaD
Rifabutin—Anaemia—Dactinomycin—sarcoma	0.000841	0.00373	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Androgen receptor activity—SRC—sarcoma	0.000838	0.00382	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CREB1—sarcoma	0.000836	0.0038	CbGpPWpGaD
Rifabutin—Eructation—Epirubicin—sarcoma	0.000829	0.00368	CcSEcCtD
Rifabutin—Blood bilirubin increased—Doxorubicin—sarcoma	0.000826	0.00367	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000823	0.00375	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000823	0.00375	CbGpPWpGaD
Rifabutin—Jaundice—Etoposide—sarcoma	0.000821	0.00365	CcSEcCtD
Rifabutin—Leukopenia—Thiotepa—sarcoma	0.00082	0.00364	CcSEcCtD
Rifabutin—Leukopenia—Dactinomycin—sarcoma	0.000814	0.00362	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—KDR—sarcoma	0.000797	0.00363	CbGpPWpGaD
Rifabutin—Hepatobiliary disease—Etoposide—sarcoma	0.000797	0.00354	CcSEcCtD
Rifabutin—Convulsion—Thiotepa—sarcoma	0.000794	0.00353	CcSEcCtD
Rifabutin—HSP90AA1—Class I PI3K signaling events—KRAS—sarcoma	0.000791	0.0036	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD34—sarcoma	0.000788	0.00359	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—IL2—sarcoma	0.000787	0.00358	CbGpPWpGaD
Rifabutin—CYP1A2—liver—sarcoma	0.000786	0.00415	CbGeAlD
Rifabutin—Agranulocytosis—Etoposide—sarcoma	0.000786	0.00349	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.000781	0.00347	CcSEcCtD
Rifabutin—Arthralgia—Thiotepa—sarcoma	0.00078	0.00346	CcSEcCtD
Rifabutin—Myalgia—Thiotepa—sarcoma	0.00078	0.00346	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000777	0.00354	CbGpPWpGaD
Rifabutin—Dysgeusia—Mitoxantrone—sarcoma	0.000775	0.00344	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000775	0.00344	CcSEcCtD
Rifabutin—Myalgia—Dactinomycin—sarcoma	0.000774	0.00344	CcSEcCtD
Rifabutin—Eructation—Doxorubicin—sarcoma	0.000767	0.00341	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—CCND1—sarcoma	0.000767	0.00349	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—JUN—sarcoma	0.000765	0.00348	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—MMP2—sarcoma	0.000765	0.00348	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—sarcoma	0.00076	0.00346	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—MDM2—sarcoma	0.000758	0.00345	CbGpPWpGaD
Rifabutin—Confusional state—Thiotepa—sarcoma	0.000754	0.00335	CcSEcCtD
Rifabutin—Anaemia—Vincristine—sarcoma	0.000751	0.00333	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—EZR—sarcoma	0.000734	0.00334	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Thiotepa—sarcoma	0.000732	0.00325	CcSEcCtD
Rifabutin—Anaemia—Mitoxantrone—sarcoma	0.000731	0.00325	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—SRC—sarcoma	0.00073	0.00332	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—FOXO1—sarcoma	0.000729	0.00332	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—TP53—sarcoma	0.000729	0.00332	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—PDGFRB—sarcoma	0.000728	0.00331	CbGpPWpGaD
Rifabutin—Leukopenia—Vincristine—sarcoma	0.000727	0.00323	CcSEcCtD
Rifabutin—Thrombocytopenia—Dactinomycin—sarcoma	0.000727	0.00323	CcSEcCtD
Rifabutin—Skin disorder—Thiotepa—sarcoma	0.000726	0.00323	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—PDGFRA—sarcoma	0.000716	0.00326	CbGpPWpGaD
Rifabutin—Anorexia—Thiotepa—sarcoma	0.000713	0.00317	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—VEGFA—sarcoma	0.000711	0.00324	CbGpPWpGaD
Rifabutin—Leukopenia—Mitoxantrone—sarcoma	0.000708	0.00315	CcSEcCtD
Rifabutin—Anorexia—Dactinomycin—sarcoma	0.000708	0.00314	CcSEcCtD
Rifabutin—Eye disorder—Etoposide—sarcoma	0.000707	0.00314	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.000704	0.00313	CcSEcCtD
Rifabutin—Convulsion—Vincristine—sarcoma	0.000704	0.00313	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—STAG1—sarcoma	0.000695	0.00316	CbGpPWpGaD
Rifabutin—Myalgia—Vincristine—sarcoma	0.000692	0.00307	CcSEcCtD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—SRC—sarcoma	0.000686	0.00313	CbGpPWpGaD
Rifabutin—Convulsion—Mitoxantrone—sarcoma	0.000686	0.00304	CcSEcCtD
Rifabutin—Immune system disorder—Etoposide—sarcoma	0.000683	0.00303	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000681	0.00303	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—FOXO1—sarcoma	0.000679	0.00309	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PDGFRB—sarcoma	0.000678	0.00309	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL2—sarcoma	0.000677	0.00308	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000676	0.003	CcSEcCtD
Rifabutin—Arthralgia—Mitoxantrone—sarcoma	0.000674	0.00299	CcSEcCtD
Rifabutin—Myalgia—Mitoxantrone—sarcoma	0.000674	0.00299	CcSEcCtD
Rifabutin—Chest pain—Mitoxantrone—sarcoma	0.000674	0.00299	CcSEcCtD
Rifabutin—HSP90AA1—Class I PI3K signaling events—HRAS—sarcoma	0.000672	0.00306	CbGpPWpGaD
Rifabutin—Paraesthesia—Thiotepa—sarcoma	0.000672	0.00298	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—FOXO1—sarcoma	0.00067	0.00305	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PDGFRB—sarcoma	0.000669	0.00305	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—sarcoma	0.000669	0.00304	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PDGFRA—sarcoma	0.000668	0.00304	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000661	0.00301	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—JUN—sarcoma	0.000659	0.003	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PDGFRA—sarcoma	0.000659	0.003	CbGpPWpGaD
Rifabutin—Dyspepsia—Thiotepa—sarcoma	0.000658	0.00292	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.000652	0.00289	CcSEcCtD
Rifabutin—Confusional state—Mitoxantrone—sarcoma	0.000651	0.00289	CcSEcCtD
Rifabutin—Decreased appetite—Thiotepa—sarcoma	0.00065	0.00289	CcSEcCtD
Rifabutin—Thrombocytopenia—Vincristine—sarcoma	0.000649	0.00288	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Thiotepa—sarcoma	0.000646	0.00287	CcSEcCtD
Rifabutin—Decreased appetite—Dactinomycin—sarcoma	0.000645	0.00287	CcSEcCtD
Rifabutin—Dysgeusia—Etoposide—sarcoma	0.000645	0.00286	CcSEcCtD
Rifabutin—Pain—Thiotepa—sarcoma	0.00064	0.00284	CcSEcCtD
Rifabutin—Shock—Mitoxantrone—sarcoma	0.000635	0.00282	CcSEcCtD
Rifabutin—Pain—Dactinomycin—sarcoma	0.000635	0.00282	CcSEcCtD
Rifabutin—Thrombocytopenia—Mitoxantrone—sarcoma	0.000632	0.00281	CcSEcCtD
Rifabutin—Anorexia—Vincristine—sarcoma	0.000632	0.00281	CcSEcCtD
Rifabutin—Skin disorder—Mitoxantrone—sarcoma	0.000627	0.00279	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—STAG1—sarcoma	0.000621	0.00283	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—IL2—sarcoma	0.000618	0.00281	CbGpPWpGaD
Rifabutin—Feeling abnormal—Thiotepa—sarcoma	0.000616	0.00274	CcSEcCtD
Rifabutin—Anorexia—Mitoxantrone—sarcoma	0.000616	0.00273	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—MYC—sarcoma	0.000615	0.0028	CbGpPWpGaD
Rifabutin—Feeling abnormal—Dactinomycin—sarcoma	0.000612	0.00272	CcSEcCtD
Rifabutin—Gastrointestinal pain—Thiotepa—sarcoma	0.000612	0.00272	CcSEcCtD
Rifabutin—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	0.00061	0.00278	CbGpPWpGaD
Rifabutin—Anaemia—Etoposide—sarcoma	0.000608	0.0027	CcSEcCtD
Rifabutin—Gastrointestinal pain—Dactinomycin—sarcoma	0.000607	0.0027	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—PTPRC—sarcoma	0.000606	0.00276	CbGpPWpGaD
Rifabutin—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	0.000605	0.00275	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000604	0.00268	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—EGFR—sarcoma	0.000602	0.00274	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—JUN—sarcoma	0.000601	0.00274	CbGpPWpGaD
Rifabutin—Insomnia—Vincristine—sarcoma	0.0006	0.00266	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—MYOD1—sarcoma	0.000598	0.00272	CbGpPWpGaD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—SRC—sarcoma	0.000597	0.00272	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CTNNB1—sarcoma	0.000596	0.00272	CbGpPWpGaD
Rifabutin—Paraesthesia—Vincristine—sarcoma	0.000595	0.00264	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—PLCG1—sarcoma	0.000593	0.0027	CbGpPWpGaD
Rifabutin—Body temperature increased—Thiotepa—sarcoma	0.000591	0.00263	CcSEcCtD
Rifabutin—Abdominal pain—Thiotepa—sarcoma	0.000591	0.00263	CcSEcCtD
Rifabutin—Leukopenia—Etoposide—sarcoma	0.000589	0.00262	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000588	0.00261	CcSEcCtD
Rifabutin—Body temperature increased—Dactinomycin—sarcoma	0.000587	0.00261	CcSEcCtD
Rifabutin—Abdominal pain—Dactinomycin—sarcoma	0.000587	0.00261	CcSEcCtD
Rifabutin—Paraesthesia—Mitoxantrone—sarcoma	0.00058	0.00258	CcSEcCtD
Rifabutin—Decreased appetite—Vincristine—sarcoma	0.000576	0.00256	CcSEcCtD
Rifabutin—Dyspnoea—Mitoxantrone—sarcoma	0.000576	0.00256	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Vincristine—sarcoma	0.000573	0.00254	CcSEcCtD
Rifabutin—Convulsion—Etoposide—sarcoma	0.00057	0.00253	CcSEcCtD
Rifabutin—HSP90B1—Immune System—PTPRC—sarcoma	0.00057	0.00259	CbGpPWpGaD
Rifabutin—CYP3A4—liver—sarcoma	0.000569	0.00301	CbGeAlD
Rifabutin—Dyspepsia—Mitoxantrone—sarcoma	0.000569	0.00252	CcSEcCtD
Rifabutin—Pain—Vincristine—sarcoma	0.000567	0.00252	CcSEcCtD
Rifabutin—Decreased appetite—Mitoxantrone—sarcoma	0.000561	0.00249	CcSEcCtD
Rifabutin—Chest pain—Etoposide—sarcoma	0.00056	0.00249	CcSEcCtD
Rifabutin—HSP90B1—Immune System—PLCG1—sarcoma	0.000558	0.00254	CbGpPWpGaD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000557	0.00247	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—KIT—sarcoma	0.000556	0.00253	CbGpPWpGaD
Rifabutin—Pain—Mitoxantrone—sarcoma	0.000552	0.00245	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000552	0.00245	CcSEcCtD
Rifabutin—Hypersensitivity—Thiotepa—sarcoma	0.000551	0.00245	CcSEcCtD
Rifabutin—Hypersensitivity—Dactinomycin—sarcoma	0.000547	0.00243	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MYC—sarcoma	0.000546	0.00248	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Vincristine—sarcoma	0.000542	0.00241	CcSEcCtD
Rifabutin—Confusional state—Etoposide—sarcoma	0.000542	0.00241	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00054	0.0024	CcSEcCtD
Rifabutin—Asthenia—Thiotepa—sarcoma	0.000537	0.00238	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—NPM1—sarcoma	0.000533	0.00243	CbGpPWpGaD
Rifabutin—Asthenia—Dactinomycin—sarcoma	0.000533	0.00236	CcSEcCtD
Rifabutin—Feeling abnormal—Mitoxantrone—sarcoma	0.000532	0.00236	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—SRC—sarcoma	0.00053	0.00241	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ATF1—sarcoma	0.00053	0.00241	CbGpPWpGaD
Rifabutin—Pruritus—Thiotepa—sarcoma	0.000529	0.00235	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—CREB1—sarcoma	0.000529	0.00241	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—CTNNB1—sarcoma	0.000528	0.00241	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000528	0.00235	CcSEcCtD
Rifabutin—Thrombocytopenia—Etoposide—sarcoma	0.000526	0.00234	CcSEcCtD
Rifabutin—Eosinophilia—Epirubicin—sarcoma	0.000524	0.00233	CcSEcCtD
Rifabutin—Abdominal pain—Vincristine—sarcoma	0.000524	0.00233	CcSEcCtD
Rifabutin—Body temperature increased—Vincristine—sarcoma	0.000524	0.00233	CcSEcCtD
Rifabutin—Skin disorder—Etoposide—sarcoma	0.000522	0.00232	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—NRAS—sarcoma	0.000519	0.00236	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—KIT—sarcoma	0.000518	0.00236	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—VEGFA—sarcoma	0.000516	0.00235	CbGpPWpGaD
Rifabutin—Anorexia—Etoposide—sarcoma	0.000512	0.00227	CcSEcCtD
Rifabutin—Diarrhoea—Thiotepa—sarcoma	0.000512	0.00227	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—KIT—sarcoma	0.000511	0.00233	CbGpPWpGaD
Rifabutin—Body temperature increased—Mitoxantrone—sarcoma	0.000511	0.00227	CcSEcCtD
Rifabutin—Abdominal pain—Mitoxantrone—sarcoma	0.000511	0.00227	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00051	0.00227	CcSEcCtD
Rifabutin—Diarrhoea—Dactinomycin—sarcoma	0.000508	0.00226	CcSEcCtD
Rifabutin—Pancytopenia—Epirubicin—sarcoma	0.000503	0.00223	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.0005	0.00222	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—CTNNB1—sarcoma	0.000499	0.00227	CbGpPWpGaD
Rifabutin—Neutropenia—Epirubicin—sarcoma	0.000495	0.0022	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CREB1—sarcoma	0.000493	0.00224	CbGpPWpGaD
Rifabutin—Hypersensitivity—Vincristine—sarcoma	0.000489	0.00217	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—CREB1—sarcoma	0.000486	0.00221	CbGpPWpGaD
Rifabutin—Eosinophilia—Doxorubicin—sarcoma	0.000485	0.00215	CcSEcCtD
Rifabutin—Paraesthesia—Etoposide—sarcoma	0.000482	0.00214	CcSEcCtD
Rifabutin—Dyspnoea—Etoposide—sarcoma	0.000479	0.00213	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—SRC—sarcoma	0.000478	0.00217	CbGpPWpGaD
Rifabutin—Hypersensitivity—Mitoxantrone—sarcoma	0.000476	0.00211	CcSEcCtD
Rifabutin—Asthenia—Vincristine—sarcoma	0.000476	0.00211	CcSEcCtD
Rifabutin—Vomiting—Thiotepa—sarcoma	0.000476	0.00211	CcSEcCtD
Rifabutin—Vomiting—Dactinomycin—sarcoma	0.000472	0.0021	CcSEcCtD
Rifabutin—Rash—Thiotepa—sarcoma	0.000472	0.00209	CcSEcCtD
Rifabutin—Dermatitis—Thiotepa—sarcoma	0.000471	0.00209	CcSEcCtD
Rifabutin—Headache—Thiotepa—sarcoma	0.000469	0.00208	CcSEcCtD
Rifabutin—Rash—Dactinomycin—sarcoma	0.000468	0.00208	CcSEcCtD
Rifabutin—Decreased appetite—Etoposide—sarcoma	0.000467	0.00207	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—sarcoma	0.000465	0.00207	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—sarcoma	0.000465	0.00212	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Etoposide—sarcoma	0.000464	0.00206	CcSEcCtD
Rifabutin—Asthenia—Mitoxantrone—sarcoma	0.000463	0.00206	CcSEcCtD
Rifabutin—Jaundice—Epirubicin—sarcoma	0.00046	0.00204	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—NRAS—sarcoma	0.00046	0.00209	CbGpPWpGaD
Rifabutin—Pain—Etoposide—sarcoma	0.000459	0.00204	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—sarcoma	0.000458	0.00203	CcSEcCtD
Rifabutin—Diarrhoea—Vincristine—sarcoma	0.000454	0.00201	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—SRC—sarcoma	0.000451	0.00205	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—sarcoma	0.000448	0.00204	CbGpPWpGaD
Rifabutin—Hepatobiliary disease—Epirubicin—sarcoma	0.000447	0.00198	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—KRAS—sarcoma	0.000446	0.00203	CbGpPWpGaD
Rifabutin—Nausea—Thiotepa—sarcoma	0.000444	0.00197	CcSEcCtD
Rifabutin—Feeling abnormal—Etoposide—sarcoma	0.000443	0.00197	CcSEcCtD
Rifabutin—Diarrhoea—Mitoxantrone—sarcoma	0.000442	0.00196	CcSEcCtD
Rifabutin—Nausea—Dactinomycin—sarcoma	0.000441	0.00196	CcSEcCtD
Rifabutin—Agranulocytosis—Epirubicin—sarcoma	0.000441	0.00196	CcSEcCtD
Rifabutin—Gastrointestinal pain—Etoposide—sarcoma	0.000439	0.00195	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—VEGFA—sarcoma	0.000439	0.002	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—MDM2—sarcoma	0.000438	0.00199	CbGpPWpGaD
Rifabutin—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000435	0.00198	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—sarcoma	0.000435	0.00198	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—NRAS—sarcoma	0.000434	0.00197	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—PTPRC—sarcoma	0.000432	0.00197	CbGpPWpGaD
Rifabutin—Jaundice—Doxorubicin—sarcoma	0.000426	0.00189	CcSEcCtD
Rifabutin—Body temperature increased—Etoposide—sarcoma	0.000425	0.00189	CcSEcCtD
Rifabutin—Abdominal pain—Etoposide—sarcoma	0.000425	0.00189	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—sarcoma	0.000424	0.00188	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—PLCG1—sarcoma	0.000423	0.00193	CbGpPWpGaD
Rifabutin—Vomiting—Vincristine—sarcoma	0.000422	0.00187	CcSEcCtD
Rifabutin—Rash—Vincristine—sarcoma	0.000418	0.00186	CcSEcCtD
Rifabutin—Dermatitis—Vincristine—sarcoma	0.000418	0.00186	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—sarcoma	0.000417	0.00185	CcSEcCtD
Rifabutin—Headache—Vincristine—sarcoma	0.000415	0.00184	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—sarcoma	0.000413	0.00183	CcSEcCtD
Rifabutin—Vomiting—Mitoxantrone—sarcoma	0.000411	0.00182	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—sarcoma	0.000408	0.00181	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—MDM2—sarcoma	0.000408	0.00186	CbGpPWpGaD
Rifabutin—Rash—Mitoxantrone—sarcoma	0.000407	0.00181	CcSEcCtD
Rifabutin—Dermatitis—Mitoxantrone—sarcoma	0.000407	0.00181	CcSEcCtD
Rifabutin—Headache—Mitoxantrone—sarcoma	0.000405	0.0018	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—MDM2—sarcoma	0.000402	0.00183	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—MMP2—sarcoma	0.000401	0.00182	CbGpPWpGaD
Rifabutin—Eye disorder—Epirubicin—sarcoma	0.000396	0.00176	CcSEcCtD
Rifabutin—Hypersensitivity—Etoposide—sarcoma	0.000396	0.00176	CcSEcCtD
Rifabutin—HSP90B1—Immune System—FOXO1—sarcoma	0.000396	0.0018	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—KRAS—sarcoma	0.000396	0.0018	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PDGFRB—sarcoma	0.000395	0.0018	CbGpPWpGaD
Rifabutin—Nausea—Vincristine—sarcoma	0.000394	0.00175	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—sarcoma	0.000392	0.00174	CcSEcCtD
Rifabutin—HSP90B1—Immune System—PDGFRA—sarcoma	0.000389	0.00177	CbGpPWpGaD
Rifabutin—Asthenia—Etoposide—sarcoma	0.000385	0.00171	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—sarcoma	0.000385	0.00171	CcSEcCtD
Rifabutin—Nausea—Mitoxantrone—sarcoma	0.000384	0.0017	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—sarcoma	0.000383	0.0017	CcSEcCtD
Rifabutin—Pruritus—Etoposide—sarcoma	0.00038	0.00169	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—HRAS—sarcoma	0.000379	0.00173	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PLCG1—sarcoma	0.000374	0.0017	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—KRAS—sarcoma	0.000373	0.0017	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—HRAS—sarcoma	0.000373	0.0017	CbGpPWpGaD
Rifabutin—Diarrhoea—Etoposide—sarcoma	0.000368	0.00163	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—sarcoma	0.000367	0.00163	CcSEcCtD
Rifabutin—Flatulence—Epirubicin—sarcoma	0.000364	0.00161	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—sarcoma	0.000361	0.0016	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—ATF1—sarcoma	0.000355	0.00162	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—JUN—sarcoma	0.000354	0.00161	CbGpPWpGaD
Rifabutin—Immune system disorder—Doxorubicin—sarcoma	0.000354	0.00157	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CTNNB1—sarcoma	0.000352	0.0016	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KDR—sarcoma	0.000348	0.00158	CbGpPWpGaD
Rifabutin—Vomiting—Etoposide—sarcoma	0.000342	0.00152	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—SRC—sarcoma	0.000341	0.00155	CbGpPWpGaD
Rifabutin—Anaemia—Epirubicin—sarcoma	0.000341	0.00151	CcSEcCtD
Rifabutin—Rash—Etoposide—sarcoma	0.000339	0.0015	CcSEcCtD
Rifabutin—Dermatitis—Etoposide—sarcoma	0.000338	0.0015	CcSEcCtD
Rifabutin—Headache—Etoposide—sarcoma	0.000337	0.00149	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—sarcoma	0.000336	0.00149	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—sarcoma	0.000336	0.00153	CbGpPWpGaD
Rifabutin—Dysgeusia—Doxorubicin—sarcoma	0.000334	0.00148	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—sarcoma	0.00033	0.00147	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—NRAS—sarcoma	0.000328	0.00149	CbGpPWpGaD
Rifabutin—Convulsion—Epirubicin—sarcoma	0.00032	0.00142	CcSEcCtD
Rifabutin—Nausea—Etoposide—sarcoma	0.000319	0.00142	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—SRC—sarcoma	0.000318	0.00145	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—HRAS—sarcoma	0.000317	0.00144	CbGpPWpGaD
Rifabutin—Anaemia—Doxorubicin—sarcoma	0.000316	0.0014	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—sarcoma	0.000314	0.00139	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—sarcoma	0.000314	0.00139	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—sarcoma	0.000314	0.00139	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—SRC—sarcoma	0.000314	0.00143	CbGpPWpGaD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000312	0.00139	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CD34—sarcoma	0.000308	0.0014	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—CTNNB1—sarcoma	0.000307	0.0014	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—NRAS—sarcoma	0.000306	0.00139	CbGpPWpGaD
Rifabutin—Leukopenia—Doxorubicin—sarcoma	0.000306	0.00136	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—CREB1—sarcoma	0.000305	0.00139	CbGpPWpGaD
Rifabutin—Confusional state—Epirubicin—sarcoma	0.000304	0.00135	CcSEcCtD
Rifabutin—HSP90AA1—Disease—TLE1—sarcoma	0.000303	0.00138	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—NRAS—sarcoma	0.000302	0.00137	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KIT—sarcoma	0.000301	0.00137	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—FOXO1—sarcoma	0.0003	0.00137	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—EGFR—sarcoma	0.000299	0.00136	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—MDM2—sarcoma	0.000297	0.00135	CbGpPWpGaD
Rifabutin—Shock—Epirubicin—sarcoma	0.000296	0.00132	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—sarcoma	0.000296	0.00131	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—sarcoma	0.000295	0.00131	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—sarcoma	0.000292	0.0013	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—sarcoma	0.000291	0.00129	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—sarcoma	0.000291	0.00129	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—sarcoma	0.000291	0.00129	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000289	0.00128	CcSEcCtD
Rifabutin—Anorexia—Epirubicin—sarcoma	0.000287	0.00127	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CREB1—sarcoma	0.000287	0.00131	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP2—sarcoma	0.000284	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—KRAS—sarcoma	0.000282	0.00129	CbGpPWpGaD
Rifabutin—Confusional state—Doxorubicin—sarcoma	0.000281	0.00125	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—EGFR—sarcoma	0.000279	0.00127	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—EGFR—sarcoma	0.000275	0.00125	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000274	0.00122	CcSEcCtD
Rifabutin—Shock—Doxorubicin—sarcoma	0.000274	0.00122	CcSEcCtD
Rifabutin—HSP90AA1—Disease—NPM1—sarcoma	0.000273	0.00124	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Doxorubicin—sarcoma	0.000273	0.00121	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—sarcoma	0.000272	0.00121	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—sarcoma	0.000271	0.0012	CcSEcCtD
Rifabutin—Paraesthesia—Epirubicin—sarcoma	0.00027	0.0012	CcSEcCtD
Rifabutin—Dyspnoea—Epirubicin—sarcoma	0.000268	0.00119	CcSEcCtD
Rifabutin—Anorexia—Doxorubicin—sarcoma	0.000266	0.00118	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—FOXO1—sarcoma	0.000265	0.00121	CbGpPWpGaD
Rifabutin—Dyspepsia—Epirubicin—sarcoma	0.000265	0.00118	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—PDGFRB—sarcoma	0.000265	0.00121	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—KRAS—sarcoma	0.000263	0.0012	CbGpPWpGaD
Rifabutin—Decreased appetite—Epirubicin—sarcoma	0.000262	0.00116	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—PDGFRA—sarcoma	0.000261	0.00119	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Epirubicin—sarcoma	0.00026	0.00115	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—KRAS—sarcoma	0.00026	0.00118	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—JUN—sarcoma	0.000259	0.00118	CbGpPWpGaD
Rifabutin—Pain—Epirubicin—sarcoma	0.000258	0.00114	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000254	0.00113	CcSEcCtD
Rifabutin—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	0.000253	0.00115	CbGpPWpGaD
Rifabutin—Insomnia—Doxorubicin—sarcoma	0.000252	0.00112	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—sarcoma	0.00025	0.00111	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—sarcoma	0.000248	0.0011	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—KDR—sarcoma	0.000248	0.00113	CbGpPWpGaD
Rifabutin—Feeling abnormal—Epirubicin—sarcoma	0.000248	0.0011	CcSEcCtD
Rifabutin—Gastrointestinal pain—Epirubicin—sarcoma	0.000246	0.00109	CcSEcCtD
Rifabutin—Dyspepsia—Doxorubicin—sarcoma	0.000245	0.00109	CcSEcCtD
Rifabutin—Decreased appetite—Doxorubicin—sarcoma	0.000242	0.00108	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000241	0.00107	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—HRAS—sarcoma	0.00024	0.00109	CbGpPWpGaD
Rifabutin—Pain—Doxorubicin—sarcoma	0.000238	0.00106	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—sarcoma	0.000238	0.00106	CcSEcCtD
Rifabutin—Body temperature increased—Epirubicin—sarcoma	0.000238	0.00106	CcSEcCtD
Rifabutin—HSP90B1—Immune System—MDM2—sarcoma	0.000237	0.00108	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ENO2—sarcoma	0.000237	0.00108	CbGpPWpGaD
Rifabutin—Feeling abnormal—Doxorubicin—sarcoma	0.00023	0.00102	CcSEcCtD
Rifabutin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000228	0.00101	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000226	0.00103	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—sarcoma	0.000226	0.00103	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HRAS—sarcoma	0.000224	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTPRC—sarcoma	0.000222	0.00101	CbGpPWpGaD
Rifabutin—Hypersensitivity—Epirubicin—sarcoma	0.000222	0.000985	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—HRAS—sarcoma	0.000221	0.00101	CbGpPWpGaD
Rifabutin—Body temperature increased—Doxorubicin—sarcoma	0.00022	0.000978	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—sarcoma	0.00022	0.000978	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.00022	0.001	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CREB1—sarcoma	0.000218	0.000992	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PLCG1—sarcoma	0.000218	0.000991	CbGpPWpGaD
Rifabutin—Asthenia—Epirubicin—sarcoma	0.000216	0.000959	CcSEcCtD
Rifabutin—Pruritus—Epirubicin—sarcoma	0.000213	0.000946	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—TLE1—sarcoma	0.000212	0.000967	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL2—sarcoma	0.000212	0.000966	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ATF1—sarcoma	0.000207	0.000942	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—JUN—sarcoma	0.000206	0.00094	CbGpPWpGaD
Rifabutin—Diarrhoea—Epirubicin—sarcoma	0.000206	0.000915	CcSEcCtD
Rifabutin—Hypersensitivity—Doxorubicin—sarcoma	0.000205	0.000912	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CTNNB1—sarcoma	0.000205	0.000932	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP2—sarcoma	0.000203	0.000923	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KIT—sarcoma	0.000202	0.00092	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PLCG1—sarcoma	0.000201	0.000915	CbGpPWpGaD
Rifabutin—Asthenia—Doxorubicin—sarcoma	0.0002	0.000888	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—ENO2—sarcoma	0.000198	0.000903	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000197	0.000899	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000197	0.000899	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—HBA1—sarcoma	0.000197	0.000897	CbGpPWpGaD
Rifabutin—Pruritus—Doxorubicin—sarcoma	0.000197	0.000875	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—SRC—sarcoma	0.000197	0.000896	CbGpPWpGaD
Rifabutin—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000195	0.00089	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CXCR4—sarcoma	0.000193	0.000879	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CREB1—sarcoma	0.000192	0.000876	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000192	0.000875	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—sarcoma	0.000192	0.000873	CbGpPWpGaD
Rifabutin—Vomiting—Epirubicin—sarcoma	0.000191	0.00085	CcSEcCtD
Rifabutin—Diarrhoea—Doxorubicin—sarcoma	0.000191	0.000847	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.00019	0.000865	CbGpPWpGaD
Rifabutin—Rash—Epirubicin—sarcoma	0.00019	0.000843	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—sarcoma	0.00019	0.000842	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—NRAS—sarcoma	0.000189	0.000862	CbGpPWpGaD
Rifabutin—Headache—Epirubicin—sarcoma	0.000189	0.000838	CcSEcCtD
Rifabutin—HSP90B1—Immune System—SRC—sarcoma	0.000185	0.000843	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFC—sarcoma	0.000179	0.000815	CbGpPWpGaD
Rifabutin—Nausea—Epirubicin—sarcoma	0.000179	0.000794	CcSEcCtD
Rifabutin—HSP90B1—Immune System—NRAS—sarcoma	0.000178	0.000811	CbGpPWpGaD
Rifabutin—Vomiting—Doxorubicin—sarcoma	0.000177	0.000787	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000177	0.000805	CbGpPWpGaD
Rifabutin—Rash—Doxorubicin—sarcoma	0.000176	0.00078	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—sarcoma	0.000176	0.000779	CcSEcCtD
Rifabutin—Headache—Doxorubicin—sarcoma	0.000175	0.000775	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000173	0.000788	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000173	0.000788	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—sarcoma	0.000173	0.000786	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—sarcoma	0.000171	0.000777	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PLCG1—sarcoma	0.000168	0.000766	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MDM2—sarcoma	0.000167	0.000759	CbGpPWpGaD
Rifabutin—Nausea—Doxorubicin—sarcoma	0.000166	0.000735	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000163	0.000744	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KRAS—sarcoma	0.000163	0.000742	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND1—sarcoma	0.000163	0.00074	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—sarcoma	0.000162	0.000739	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MDM2—sarcoma	0.000159	0.000725	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CTNNB1—sarcoma	0.000155	0.000708	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FOXO1—sarcoma	0.000154	0.000703	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PDGFRB—sarcoma	0.000154	0.000702	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KRAS—sarcoma	0.000153	0.000698	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PDGFRA—sarcoma	0.000152	0.000691	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—sarcoma	0.000145	0.000662	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FLT1—sarcoma	0.000143	0.000652	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FOXO1—sarcoma	0.000143	0.000649	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PDGFRB—sarcoma	0.000142	0.000648	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PLCG1—sarcoma	0.000141	0.000641	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—SRC—sarcoma	0.00014	0.00064	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PDGFRA—sarcoma	0.00014	0.000638	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000139	0.000633	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—sarcoma	0.000139	0.000631	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—JUN—sarcoma	0.000138	0.00063	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CTNNB1—sarcoma	0.000137	0.000625	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—sarcoma	0.000137	0.000623	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCR4—sarcoma	0.000135	0.000616	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NRAS—sarcoma	0.000135	0.000615	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ATF1—sarcoma	0.000134	0.000609	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—sarcoma	0.00013	0.000593	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—sarcoma	0.00013	0.000593	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—SRC—sarcoma	0.000124	0.000565	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—sarcoma	0.000123	0.000561	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NRAS—sarcoma	0.000119	0.000543	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KIT—sarcoma	0.000118	0.000536	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—sarcoma	0.000117	0.000531	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—sarcoma	0.000116	0.00053	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CREB1—sarcoma	0.000112	0.00051	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—sarcoma	0.000109	0.000495	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KIT—sarcoma	0.000109	0.000495	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1R—sarcoma	0.000105	0.000478	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CREB1—sarcoma	0.000103	0.000471	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—sarcoma	0.000103	0.000468	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FOXO1—sarcoma	9.99e-05	0.000455	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFRB—sarcoma	9.97e-05	0.000454	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—sarcoma	9.89e-05	0.00045	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFRA—sarcoma	9.81e-05	0.000447	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—sarcoma	9.57e-05	0.000436	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MDM2—sarcoma	9.27e-05	0.000422	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—sarcoma	8.73e-05	0.000398	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MDM2—sarcoma	8.56e-05	0.00039	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—sarcoma	8.28e-05	0.000377	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KDR—sarcoma	8.26e-05	0.000376	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—JUN—sarcoma	8.06e-05	0.000367	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTNNB1—sarcoma	8e-05	0.000364	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KIT—sarcoma	7.61e-05	0.000346	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CTNNB1—sarcoma	7.38e-05	0.000336	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CREB1—sarcoma	7.24e-05	0.00033	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SRC—sarcoma	7.23e-05	0.000329	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NRAS—sarcoma	6.95e-05	0.000317	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SRC—sarcoma	6.67e-05	0.000304	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NRAS—sarcoma	6.42e-05	0.000292	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—sarcoma	6.33e-05	0.000288	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MDM2—sarcoma	5.99e-05	0.000273	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—sarcoma	5.98e-05	0.000272	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—sarcoma	5.98e-05	0.000272	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—sarcoma	5.85e-05	0.000266	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—sarcoma	5.52e-05	0.000252	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—sarcoma	5.35e-05	0.000244	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—sarcoma	5.22e-05	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JUN—sarcoma	5.21e-05	0.000237	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNB1—sarcoma	5.17e-05	0.000235	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—sarcoma	5.09e-05	0.000232	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—sarcoma	4.7e-05	0.000214	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SRC—sarcoma	4.67e-05	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—sarcoma	4.55e-05	0.000207	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRAS—sarcoma	4.5e-05	0.000205	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—sarcoma	4.19e-05	0.000191	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENO2—sarcoma	4.17e-05	0.00019	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HBA1—sarcoma	4.15e-05	0.000189	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—sarcoma	4.1e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—sarcoma	3.87e-05	0.000176	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLCG1—sarcoma	3.54e-05	0.000161	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—sarcoma	3.44e-05	0.000157	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—sarcoma	3.29e-05	0.00015	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENO2—sarcoma	3.22e-05	0.000147	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HBA1—sarcoma	3.2e-05	0.000146	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLCG1—sarcoma	2.73e-05	0.000124	CbGpPWpGaD
